These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 32157196)

  • 21. TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?
    Rubbert-Roth A; Atzeni F; Masala IF; Caporali R; Montecucco C; Sarzi-Puttini P
    Autoimmun Rev; 2018 Jan; 17(1):24-28. PubMed ID: 29108829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Off-label therapy of rheumatoid arthritis and spondyloarthritis].
    Krüger K; Sieper J
    Z Rheumatol; 2012 Feb; 71(2):122-4, 126. PubMed ID: 22370803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.
    Aziz RK; Hegazy SM; Yasser R; Rizkallah MR; ElRakaiby MT
    Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1043-1055. PubMed ID: 30269615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis.
    Gulácsi L; Zrubka Z; Brodszky V; Rencz F; Alten R; Szekanecz Z; Péntek M
    Adv Ther; 2019 Mar; 36(3):721-745. PubMed ID: 30637590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis.
    Santinon F; Batignes M; Mebrek ML; Biton J; Clavel G; Hervé R; Lemeiter D; Breckler M; Busato F; Tost J; Ziol M; Boissier MC; Decker P; Semerano L; Bessis N
    Arthritis Rheumatol; 2020 Apr; 72(4):576-587. PubMed ID: 31609517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The issue of bioavailability of oral low dose methotrexate: should we choose only 10 mg of MTX a week in conjunction with anti-TNF therapy?
    Zeidler H
    Ann Rheum Dis; 2014 Aug; 73(8):e50. PubMed ID: 24764450
    [No Abstract]   [Full Text] [Related]  

  • 27. Biological drug treatment of rheumatoid arthritis and spondyloarthritis: effects on QT interval and QT dispersion.
    DI Franco M; Paradiso M; Ceccarelli F; Scrivo R; Spinelli FR; Iannuccelli C; Valesini G
    J Rheumatol; 2012 Jan; 39(1):41-5. PubMed ID: 22045840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating upadacitinib for the treatment of rheumatoid arthritis.
    Mysler E; Lizarraga A
    Expert Opin Pharmacother; 2020 Sep; 21(13):1527-1536. PubMed ID: 32515665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Colebatch AN; Marks JL; Edwards CJ
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008872. PubMed ID: 22071858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy.
    Zaragoza-García O; Castro-Alarcón N; Pérez-Rubio G; Guzmán-Guzmán IP
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33114390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate: vital new information about a middle aged drug.
    Giannini EH
    J Rheumatol; 2002 Oct; 29(10):2031-3. PubMed ID: 12375307
    [No Abstract]   [Full Text] [Related]  

  • 32. Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.
    Prescrire Int; 2010 Feb; 19(105):30-4. PubMed ID: 20455343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human microbiome, infections, and rheumatic disease.
    Caminer AC; Haberman R; Scher JU
    Clin Rheumatol; 2017 Dec; 36(12):2645-2653. PubMed ID: 29101674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of the Microbiome in Gut and Joint Inflammation in Psoriatic Arthritis and Spondyloarthritis.
    Gilis E; Mortier C; Venken K; Debusschere K; Vereecke L; Elewaut D
    J Rheumatol Suppl; 2018 Jun; 94():36-39. PubMed ID: 29858352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis.
    Pantano I; Mauro D; Simone D; Costa L; Capocotta D; Raimondo M; Birra D; Cuomo G; D'Errico T; Ferrucci M; Comentale F; Italiano G; Moscato P; Pappone N; Russo R; Scarpato S; Tirri R; Buono P; Postiglione A; Guida R; Scarpa R; Trama U; Tirri E; Ciccia F
    Reumatismo; 2023 Mar; 74(4):. PubMed ID: 36942981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early prediction of clinical response to anti-TNF treatment using multi-omics and machine learning in rheumatoid arthritis.
    Yoosuf N; Maciejewski M; Ziemek D; Jelinsky SA; Folkersen L; Müller M; Sahlström P; Vivar N; Catrina A; Berg L; Klareskog L; Padyukov L; Brynedal B
    Rheumatology (Oxford); 2022 Apr; 61(4):1680-1689. PubMed ID: 34175943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the treatment of inflammatory arthritis.
    Pisetsky DS; Ward MM
    Best Pract Res Clin Rheumatol; 2012 Apr; 26(2):251-61. PubMed ID: 22794097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides.
    Govoni M; Bortoluzzi A; Lo Monaco A; Adami S; Addimanda O; Caimmi C; De Vita S; Ferri C; Manfredi A; Orsolini G; Possemato N; Quartuccio L; Salvarani C; Zabotti A; Rossini M
    Adv Ther; 2014 Aug; 31(8):780-802. PubMed ID: 25112460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The intestinal microbiome in human disease and how it relates to arthritis and spondyloarthritis.
    Costello ME; Robinson PC; Benham H; Brown MA
    Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):202-12. PubMed ID: 26362739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors.
    Mewar D; Wilson AG
    Br J Pharmacol; 2011 Feb; 162(4):785-91. PubMed ID: 21039421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.